INS and type 2 diabetes mellitus: The incidence rates of atherosclerotic cardiovascular disease and peripheral arterial disease are elevated among patients with T2DM [2, 3], and some large-scale studies have shown that exogenous insulin therapy may worsen cardiovascular outcomes in T2DM patients [4, 5].